3-year-old Divit has been diagnosed with High-Risk B-Acute Lymphoblastic Leukemia (B-ALL), an aggressive blood cancer. The disease has spread beyond the bone marrow and severely affected his spine, causing spinal cord compression and a critical neurological condition.

Recent genetic testing has revealed 3 high-risk mutations, and doctors have advised urgent Blinatumomab Immunotherapy to reduce the risk of relapse and improve survival chances.

Divit is currently undergoing treatment at Manipal Hospitals, Jaipur. The total treatment cost is estimated at ₹68–70 Lakhs, which has become extremely difficult for the family to manage despite continuous fundraising efforts and support from well-wishers.
We sincerely request your support in helping continue his life-saving treatment.